Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Neuroendocrine tumors are rare neoplasms arising from neural and epithelial origin.
Methods And Results: The case records of 4 patients with the diagnosis of neuroendocrine laryngeal tumor were retrospectively reviewed. In this analysis of our medical records, we describe a series of 4 men with neuroendocrine laryngeal tumors treated in our department since 1994, including the first extremely aggressive and lethal laryngeal paraganglioma reported in the English-language literature. We also discuss the classification, the macro and microscopical characteristics, clinical and pathologic findings, and treatment of these neoplasms.
Conclusion: Although neuroendocrine laryngeal tumors account for approximately 1% of all neoplasms in the larynx, its majority represents very aggressive tumors showing a capacity for metastasis and portending poor outcome.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hed.22955 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical impact of Ga-DOTATOC PET on treatment decisions in jugulotympanic paragangliomas: A case series.
Auris Nasus Larynx
August 2025
Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Head and Neck Oncology and Innovative Treatment, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
The study aimed to highlight the complementary roles of computed tomography (CT), magnetic resonance imaging (MRI), and gallium-68 DOTA-(Tyr³)-octreotide positron emission tomography (Ga-DOTATOC PET) in the diagnosis and treatment of jugulotympanic paragangliomas. We present cases of three patients: a 48-year-old woman with tympanic paraganglioma associated with left facial paralysis (patient 1), a 60-year-old man with asymptomatic jugular paraganglioma (patient 2), and a 73-year-old woman with a small tympanic paraganglioma (patient 3). All patients underwent CT, MRI, and Ga-DOTATOC PET imaging.
View Article and Find Full Text PDFRare Head and Neck Neuroendocrine Neoplasms: A Retrospective Study of Prognosis and Treatment Outcomes.
Cancer Diagn Progn
June 2025
Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Background/aim: Neuroendocrine neoplasms (NEN) of the head and neck (HN) region are rare, with limited reported cases. NENs are classified into neuroendocrine tumors (NET) grades G1, G2, and G3, and neuroendocrine carcinomas (NECs), with varying treatment strategies. This study investigated patient outcomes of HN-NENs and proposed a treatment algorithm based on pathological classification.
View Article and Find Full Text PDFNeuroendocrine carcinomas of the larynx: a review of current literature and case analysis.
J Surg Case Rep
June 2025
Department of Otolaryngology Head and Neck Surgery, Fabrizio Spaziani Hospital, 03100 Frosinone, Italy.
Neuroendocrine carcinomas (NECs) of the larynx are rare malignancies with aggressive behavior, histopathological diversity, and poor prognosis. Their management remains challenging due to limited case reports and the lack of standardized treatment guidelines. We conducted a comprehensive literature review to summarize classification, diagnosis, and treatment approaches for laryngeal NECs.
View Article and Find Full Text PDFLong-Term Survivor of Laryngeal Small Cell Neuroendocrine Carcinoma.
Perm J
June 2025
Department of Otolaryngology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Small cell neuroendocrine carcinoma (SCNC) of the larynx is an exceptionally rare subset of laryngeal carcinoma with a clinically aggressive course and poor prognosis. Long-term survival is rare, and treatment strategies remain nonstandardized due to limited data. In this report, the authors present a case of a 51-year-old male who presented with stage IVa laryngeal SCNC and no distant metastasis, treated with a combination of platinum-based chemotherapy and radiation, who has survived for more than 5 years.
View Article and Find Full Text PDFModification of supraglottic partial laryngectomy to preserve hyoid bone: a cadaveric study.
Eur Arch Otorhinolaryngol
September 2025
Department of Otolaryngology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, 960-1295, Japan.
Background: Supraglottic partial laryngectomy (SGPL) preserving the hyoid bone is expected to maintain laryngeal elevation by the suprahyoid muscles. However, the surgical technique has not been adequately validated. We describe the procedure, which preserves the hyoid body and suprahyoid muscle complex to maintain laryngeal elevation and provides access to the pharynx.
View Article and Find Full Text PDF